CA
NZ
UK
AU
IND
US
Seres Therapeutics is a Nasdaq-listed clinical-stage company pioneering microbiome therapeutics, live bacterial consortia designed to treat disease by modulating the gut. Its former commercial product, VOWST, was divested to Nestlé Health Science, and Seres now centers its future on SER-155, a cultivated microbiome candidate. …
Eco-Growth Strategies is a Hawaii-basedBusinessnow centered on premium bottled water production and distribution, having historically described itself as a provider of design-build infrastructure services, including telecommunications work. The company trades on the U.S. over-the-counter market, not a national exchange. Through 2026 it has publicized …
Change Agents Corporation is a developer of agentic artificial-intelligence software aimed at small businesses and content creators. Its products include Beacon, described as an AI search-optimization platform, and Catch-Up, an autonomous content-creation tool, both offered through a software-as-a-service model. The company also distributes KetoAir, …
Niagen Bioscience develops and markets nicotinamide riboside chloride, branded Niagen, in both food-grade and pharmaceutical-grade formulations, with Tru Niagen as its best-known consumer product. The company trades on theNasdaqunder the ticker NAGE following its rebranding from ChromaDex, a change investors should keep in mind …
Sionna is a clinical-stage biopharmaceutical company developing medicines for cystic fibrosis (CF), a genetic disease driven by defects in the CFTR protein. The company went public onNasdaqin February 2025 and has pursued a differentiated approach aimed at stabilizing the NBD1 region of CFTR, alongside …
CEL-SCI is a clinical-stage immunotherapy company whose lead asset, Multikine (leukocyte interleukin injection), is being developed for certain head and neck cancers. In 2026 the company advanced on several fronts. On July 13, 2026, it launched a global, roughly 212-patient confirmatory registration Phase 3 …
Artelo Biosciences (NASDAQ: ARTL) is a clinical-stage biopharmaceutical company built around the biology of lipids and the endocannabinoid system. Its portfolio spans oncology-supportive care, pain and metabolic health. In its second-quarter 2026 update, released in August, the company reiterated progress across three programs and …
iTonic Holdings Ltd (NASDAQ: ITOC) is a healthcare technology company focused on brachytherapy, a form of cancer treatment that places radioactive sources inside or next to a tumor. The company develops treatment-planning systems and related software used in radiotherapy, and it is headquartered in …
Pulmatrix, Inc (NASDAQ: PULM) is a clinical-stage biotechnology company historically known for its iSPERSE inhaled dry-powder platform. In recent quarters it has functioned largely as a small, cash-conserving Nasdaq-listed shell seeking a strategic combination.
CalciMedica, Inc (NASDAQ: CALC) is a clinical-stage biopharmaceutical company developing Auxora, an intravenous inhibitor of calcium release-activated calcium (CRAC) channels. Its primary focus is acute pancreatitis (AP), a serious inflammatory condition with no approved targeted therapy.
Please wait processing your request...